MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about schedule of analyst meet

25 Jan 2019 Evaluate

Pursuant to Regulation 30(6) of the Schedule lll, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed about the schedule of Analyst or Institutional Meetings with the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..